Success Stories

Event Videos

Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis http://www.ncbi.nlm.nih.gov/pubmed/24988903 Aoyama T, Oka S, Aikata H, Igawa A, Nakano M, Naeshiro N, Yoshida S, Tanaka S, Chayama K. Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis. J Gastroenterol Hepatol. 2015 Jan; 30(1):124-30. Abstract BACKGROUND AND AIM: Portal hypertensive enteropathy (PHE) is acknowledged as a source of bleeding, and predicting its presence has become more important. We assessed PHE using capsule endoscopy (CE) and investigated factors that may predict its presence, including portosystemic shunts (PSs). METHODS: Published on: Jan-2015 Read more	HEPATICON 2015 Hepaticon 2015 was held at Nehru Centre on 10th and 11th January 2015. It was a meeting organized by Children’s Liver Foundation (CLF) and IAP, Mumbai and endorsed by the Indian Association for study of Liver (INASL). The meeting was attended by over 300 delegates from all over the country. The format of the meeting was case discussions interspersed by a few related talks. PG students from all over the country presented cases to a team of 3 panelists who were completely oblivious to the case. The moderators ensured audience participation and good interaction. The National faculty - Dr SK Yachha and Dr Anshu Srivastava from SGPGI, Lucknow, Dr. Read more
Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity http://www.ncbi.nlm.nih.gov/pubmed/24594635 Gordo-Gilart R, Andueza S, Hierro L, Martínez-Fernández P, D'Agostino D, Jara P, Alvarez L. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity. Gut. 2015 Jan; 64(1):147-55. Abstract OBJECTIVE: Published on: Jan-2015 Read more	HEPATICON 2015 Presentations Read more
Novel strategies for liver therapy using stem cells http://www.ncbi.nlm.nih.gov/pubmed/25183202 Rashid T, Takebe T, Nakauchi H. Novel strategies for liver therapy using stem cells. Gut. 2015 Jan; 64(1):1-4. Published on: Jan-2015	Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations http://www.ncbi.nlm.nih.gov/pubmed/25238538 Ledder O1, Haller W, Couper RT, Lewindon P, Oliver M. Abstract This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF. Published on: Dec-2014
Prevention of portal hypertension: From variceal development to clinical decompensation http://www.ncbi.nlm.nih.gov/pubmed/24913395 Vorobioff JD, Groszmann RJ. Prevention of portal hypertension: From variceal development to clinical decompensation. Hepatology. 2015 Jan; 61(1):375-81. Abstract Published on: Jan-2015 Read more	Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study http://www.ncbi.nlm.nih.gov/pubmed/25160979 Lammers WJ1, van Buuren HR1, Hirschfield GM2, Janssen HL3, Invernizzi P4, Mason AL5, Ponsioen CY6, Floreani A7, Corpechot C8, Mayo MJ9, Battezzati PM10, Parés A11, Nevens F12, Burroughs AK13, Kowdley KV14, Trivedi PJ2, Kumagi T15, Cheung A3, Lleo A4, Imam MH16, Boonstra K6, Cazzagon N7,Franceschet I7, Poupon R8, Caballeria L11, Pieri G13, Kanwar PS14, Lindor KD17, Hansen BE18; Global PBC Study Group. Abstract BACKGROUND & AIMS: Published on: Dec-2014 Read more
Treatment of bile acid amidation defects with glycocholic acid http://www.ncbi.nlm.nih.gov/pubmed/25163551 Heubi JE, Setchell KD, Jha P, Buckley D, Zhang W, Rosenthal P, Potter C, Horslen S, Suskind D. Treatment of bile acid amidation defects with glycocholic acid. Hepatology. 2015 Jan; 61(1):268-74. Abstract Published on: Jan-2015 Read more	Parenteral nutrition-associated liver injury and increased GRP94 expression prevented by ω-3 fish oil-based lipid emulsion supplementation http://www.ncbi.nlm.nih.gov/pubmed/25199039 Zhu X1, Xiao Z, Chen X, Li Y, Zhang X, Xu Y, Feng X, Wang J. Abstract OBJECTIVE: Parenteral nutrition in infants with gastrointestinal disorders can be lifesaving, but it is also associated with parenteral nutrition-associated liver disease. We investigated the effects of incorporating ω-3 fish oil in a parenteral nutrition mixture on signs of parenteral nutrition-associated liver disease and explored the mechanism involved in this process. METHODS: Published on: Dec-2014 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube